MedTrace Logo

Development and Validation of a Simulator-based Test in Transurethral Resection of Bladder Tumors

NCT03863028 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 49

Last updated 2019-03-05

No results posted yet for this study

Summary

Bladder cancer (BC) is the seventh most common cancer in men worldwide and fourth most common cancer among Danish men. BC is estimated to be the most cost expensive cancer pr. patient life. BC is diagnosed, staged and if possible treated with a transurethral bladder tumor resection (TUR-B).

The prognosis of BC is depending on the depth of invasion, which makes the quality of the TURB procedure of utmost importance. Retrospective studies from Sweden and Canada on resident involvement in TURB procedures indicated that the TURBs were insufficient with regard to staging and had a higher need of repeating TURB.

Surgical training for TURB in Denmark today is based on the Halstedian principle: "See one, do one, teach one", comparable to training in Sweden and Canada. Thus, there is a need to develop better and safer principles for training.

Simulators for surgical procedures have a promising role in the surgical training. The project will explore the effect of simulation training on the quality in transurethral resection of bladder tumors.

Based on our findings the principles of simulator training will be integrated in a curriculum for simulator-based TURB training for urological surgeons in Denmark.

The collaboration research group is composed of medical doctors in urological surgery at Urological Department at Zealand University Hospital, Roskilde (ROS) and experts in medical simulation at Copenhagen Academy for Medical Education and Simulation at Rigshospitalet (CAMES).

Conditions

  • Validity-evidence for a Simulator-based Test
  • Virtual Simulation
  • Bladder Cancer
  • Surgical Skill Training
  • Medical Education
  • Transurethral Resection of Bladdertumors

Interventions

OTHER

Simulation training

It is not a randomized trial - all three groups are exposed to simulation training.

Sponsors & Collaborators

  • Copenhagen Academy for Medical Education and Simulation

    collaborator OTHER

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-15
Primary Completion
2018-09-21
Completion
2018-09-21

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03863028 on ClinicalTrials.gov